Culturally tailored videos to promote lung cancer screening in vulnerable communities
Breathe Easier, Philadelphia! Engaging Vulnerable Communities for Innovative Lung Cancer Care
NA · Thomas Jefferson University · NCT06010355
This study tests whether specially made videos can help African American, Korean, and Chinese communities learn more about lung cancer screening and encourage them to get screened.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Thomas Jefferson University (other) |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06010355 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of culturally tailored educational videos aimed at increasing awareness and screening for lung cancer among vulnerable populations, specifically African American, Korean, and Chinese communities. The study involves three distinct arms: focus groups to gather insights, video presentations followed by interviews, and pre- and post-video assessments to measure knowledge and intent regarding lung cancer screening. By addressing cultural barriers and enhancing understanding, the trial seeks to improve lung cancer screening rates in these high-risk groups.
Who should consider this trial
Good fit: Ideal candidates include African American, Korean, or Chinese adults aged 50-80 with a history of smoking or lung cancer, or those eligible for lung cancer screening.
Not a fit: Patients who do not belong to the specified cultural groups or do not meet the smoking or screening history criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly increase lung cancer screening rates and early detection in vulnerable communities, potentially saving lives.
How similar studies have performed: While culturally tailored interventions have shown promise in other health domains, this specific approach to lung cancer screening is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIM 1: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening * AIM 2: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening * AIM 3: Those who are African American, Korean or Chinese, and are eligible for lung cancer screening, based on current screening guidelines: Current or former smokers who are between 50 and 80 years of age and who have smoked at least one pack a day for 20 years or two packs a day for 10 years Exclusion Criteria: * AIM 1: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening * AIM 2: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening * AIM 3: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have a history of smoking; those who have been diagnosed with lung cancer; those who have undergone lung cancer screening in the past
Where this trial is running
Philadelphia, Pennsylvania
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States (RECRUITING)
Study contacts
- Principal investigator: Amy R Leader, DrPH, MPH — Thomas Jefferson University
- Study coordinator: Amy Leader, DrPH, MPH
- Email: Amy.Leader@jefferson.edu
- Phone: 215-955-7739
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cigarette Smoking-Related Carcinoma, Lung Carcinoma